<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
		<id>http://www.wikiweed.com/index.php?action=history&amp;feed=atom&amp;title=JWH-133</id>
		<title>JWH-133 - Revision history</title>
		<link rel="self" type="application/atom+xml" href="http://www.wikiweed.com/index.php?action=history&amp;feed=atom&amp;title=JWH-133"/>
		<link rel="alternate" type="text/html" href="http://www.wikiweed.com/index.php?title=JWH-133&amp;action=history"/>
		<updated>2026-05-02T09:23:44Z</updated>
		<subtitle>Revision history for this page on the wiki</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://www.wikiweed.com/index.php?title=JWH-133&amp;diff=1354&amp;oldid=prev</id>
		<title>Adm1n: Created page with &quot;'''JWH-133''' is a potent selective CB2 receptor agonist, with a Ki of 3.4nM and selectivity of around 200x for CB2 over CB1 receptors. It was discovered by, and named...&quot;</title>
		<link rel="alternate" type="text/html" href="http://www.wikiweed.com/index.php?title=JWH-133&amp;diff=1354&amp;oldid=prev"/>
				<updated>2015-02-15T10:51:12Z</updated>
		
		<summary type="html">&lt;p&gt;Created page with &amp;quot;&amp;#039;&amp;#039;&amp;#039;JWH-133&amp;#039;&amp;#039;&amp;#039; is a potent selective &lt;a href=&quot;/CB2_receptor&quot; title=&quot;CB2 receptor&quot;&gt;CB2 receptor&lt;/a&gt; agonist, with a Ki of 3.4nM and selectivity of around 200x for CB2 over &lt;a href=&quot;/CB1&quot; title=&quot;CB1&quot;&gt;CB1&lt;/a&gt; receptors. It was discovered by, and named...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;'''JWH-133''' is a potent selective [[CB2 receptor]] agonist, with a Ki of 3.4nM and selectivity of around 200x for CB2 over [[CB1]] receptors. It was discovered by, and named after, John W. Huffman.&lt;br /&gt;
&lt;br /&gt;
JWH-133, alongside [[WIN 55,212-2]] and [[HU-210]], is implicated in preventing the inflammation caused by Amyloid beta proteins involved in Alzheimer's Disease, in addition to preventing cognitive impairment and loss of neuronal markers. This antiinflamatory action is induced through agonist action at [[cannabinoid receptors]], which prevents microglial activation that elicits the inflammation. Additionally, cannabinoids completely abolish neurotoxicity related to microglia activation in rat models.&lt;br /&gt;
&lt;br /&gt;
It may be linked with anti-cancer properties, according to pre-trial data from a 2010 study in Madrid.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Legal Status ==&lt;br /&gt;
&lt;br /&gt;
The substance commonly referred to as &amp;quot;JWH-133&amp;quot; is not a scheduled substance in the U.S. BANNED IN PA, although its young age prevents it from having received the level of government attention as with the older, more widely used and well known chemicals. Low abuse potential makes it less likely for regulation a priori relative to its sister drugs such as [[JWH-018]], as JWH-133 (chemical name (6aR,10aR)-3-(1,1-Dimethylbutyl)-6a,7,10,10a-tetrahydro -6,6,9-trimethyl-6H-dibenzo[b,d]pyran) is selective for the non-psychoactive CB2 receptor and hence devoid of any psychoactive side effects or abuse potential.&lt;/div&gt;</summary>
		<author><name>Adm1n</name></author>	</entry>

	</feed>